Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 47, 2017 - Issue 10
276
Views
12
CrossRef citations to date
0
Altmetric
Pharmacogenetics

Effect of hepatic drug transporter polymorphisms on the pharmacokinetics of mycophenolic acid in patients with severe renal dysfunction before renal transplantation

, , , , , , & show all
Pages 916-922 | Received 11 Jul 2016, Accepted 08 Sep 2016, Published online: 24 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Amani Abderahmene, Amel Ellouz, Dorra Amor, Marwa Ajmi, Yassine Khalij, Haithem Hamdouni, Wissal Sahtout, Awatef Azzabi, Asma Omezzine, Abdellatif Achour & Ali Bouslama. (2022) The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients. Personalized Medicine 19:5, pages 383-393.
Read now
Qing Shu, Qingqing Fan, Bingzhu Hua, Hang Liu, Shiying Wang, Yunxing Liu, Yao Yao, Han Xie & Weihong Ge. (2021) Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients. Pharmacogenomics and Personalized Medicine 14, pages 713-722.
Read now
Lauren Schumacher, Fang Fang, Kelley M Kidwell, Faisal Shakeel, Daniel L Hertz, Jeong M Park & Amy L Pasternak. (2021) SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate. Pharmacogenomics 22:17, pages 1111-1120.
Read now

Articles from other publishers (8)

Amani Abderahmene, Yassine khalij, Amira Moussa, Meriam Ammar, Amel Ellouz, Dorra Amor, Houwaida Abbes, Mohamed Rayen Ganouni, Wissal Sahtout, Saoussen Chouchene, Asma omezzine, Dorsaf zellama & Ali Bouslama. (2024) The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events. The Pharmacogenomics Journal 24:1.
Crossref
Yoshiharu Suzuki, Shingo Ishiguro, Hirokazu Shimada, Masahiro Ohgami & Mika Suzuki. (2023) Evaluation of mycophenolic acid exposure in a patient with immune-related hepatotoxicity caused by nivolumab and ipilimumab therapy for malignant melanoma: a case report. Cancer Chemotherapy and Pharmacology.
Crossref
Yumiko Akamine, Miyuki Matsushita, Satoru Morikawa & Masatomo Miura. (2023) Evaluation of Plasma Concentrations of Mycophenolic Acid in Renal Transplant Patients Using LM1010 High-performance Liquid Chromatography腎移植患者におけるミコフェノール酸血中濃度に対する高速液体クロマトグラフLM1010の精度評価. YAKUGAKU ZASSHI 143:4, pages 377-383.
Crossref
Sha‐Sha Sun, Kun Shao, Jia‐Qian Lu, Hui‐Min An, Hao‐Qiang Shi, Pei‐Jun Zhou & Bing Chen. (2022) Influence of Calcineurin Inhibitors and Genetic Polymorphism of Transporters on Enterohepatic Circulation and Exposure of Mycophenolic Acid in Chinese Adult Renal Allograft Recipients. The Journal of Clinical Pharmacology 63:4, pages 410-420.
Crossref
Mingkwan Na Takuathung, Wannachai Sakuludomkan & Nut Koonrungsesomboon. (2021) The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Systematic Review and Meta-analysis. Clinical Pharmacokinetics 60:10, pages 1291-1302.
Crossref
François Riglet, Julie Bertrand, Aurélie Barrail-Tran, Céline Verstuyft, Hugues Michelon, Henri Benech, Antoine Durrbach, Valérie Furlan & Caroline Barau. (2020) Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study. Drugs in R&D 20:4, pages 331-342.
Crossref
Jun Zhang, Zhi Sun, Zhenfeng Zhu, Jing Yang, Jian Kang, Guiwen Feng, Lin Zhou, Lihua Zuo, Yonggang Luo & Xiaojian Zhang. (2018) Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients. Frontiers in Pharmacology 9.
Crossref
Zi-cheng Yu, Pei-jun Zhou, Xiang-hui Wang, Bressolle Françoise, Da Xu, Wei-xia Zhang & Bing Chen. (2017) Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients. Acta Pharmacologica Sinica 38:11, pages 1566-1579.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.